IceCure Medical Ltd Statistics Share Statistics IceCure Medical Ltd has 68.69M
shares outstanding. The number of shares has increased by -0.01%
in one year.
Shares Outstanding 68.69M Shares Change (YoY) -0.01% Shares Change (QoQ) 0% Owned by Institutions (%) 0.26% Shares Floating 34.88M Failed to Deliver (FTD) Shares 35,996 FTD / Avg. Volume 3.4%
Short Selling Information The latest short interest is 358.41K, so 0.6% of the outstanding
shares have been sold short.
Short Interest 358.41K Short % of Shares Out 0.6% Short % of Float 7.07% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -3.65 and the forward
PE ratio is -5.16.
IceCure Medical Ltd's PEG ratio is
1.17.
PE Ratio -3.65 Forward PE -5.16 PS Ratio 17.01 Forward PS 4.2 PB Ratio 8.11 P/FCF Ratio -4.43 PEG Ratio 1.17
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for IceCure Medical Ltd.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.95,
with a Debt / Equity ratio of 0.07.
Current Ratio 1.95 Quick Ratio 1.59 Debt / Equity 0.07 Debt / EBITDA -0.03 Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $51.42K Profits Per Employee $-239.34K Employee Count 64 Asset Turnover 0.26 Inventory Turnover 0.93
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 31.36% in the
last 52 weeks. The beta is 2.35, so IceCure Medical Ltd's
price volatility has been higher than the market average.
Beta 2.35 52-Week Price Change 31.36% 50-Day Moving Average 1 200-Day Moving Average 1.07 Relative Strength Index (RSI) 30.04 Average Volume (20 Days) 1,060,077
Income Statement In the last 12 months, IceCure Medical Ltd had revenue of 3.29M
and earned -15.32M
in profits. Earnings per share was -0.31.
Revenue 3.29M Gross Profit 1.45M Operating Income -15.7M Net Income -15.32M EBITDA -15.36M EBIT -15.7M Earnings Per Share (EPS) -0.31
Full Income Statement Balance Sheet The company has 7.56M in cash and 459K in
debt, giving a net cash position of 7.11M.
Cash & Cash Equivalents 7.56M Total Debt 459K Net Cash 7.11M Retained Earnings -105.38M Total Assets 11.1M Working Capital 4.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -12.56M
and capital expenditures -71K, giving a free cash flow of -12.63M.
Operating Cash Flow -12.56M Capital Expenditures -71K Free Cash Flow -12.63M FCF Per Share -0.25
Full Cash Flow Statement Margins Gross margin is 44.09%, with operating and profit margins of -476.94% and -465.45%.
Gross Margin 44.09% Operating Margin -476.94% Pretax Margin -465.45% Profit Margin -465.45% EBITDA Margin -466.85% EBIT Margin -476.94% FCF Margin -383.9%
Dividends & Yields ICCM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ICCM is $2.5,
which is 212.5% higher than the current price. The consensus rating is "Buy".
Price Target $2.5 Price Target Difference 212.5% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 9, 2021. It was a
backward
split with a ratio of 1:8.
Last Split Date Aug 9, 2021 Split Type backward Split Ratio 1:8
Scores Altman Z-Score -10.75 Piotroski F-Score 2
